As of 2025-06-16, the Fair Value of Ascendis Pharma A/S (ASND) is -32.69 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 170.80 USD, the upside of Ascendis Pharma A/S is -119.14%.
With the market price of 170.80 USD and our fair value calculation, Ascendis Pharma A/S (ASND) is not a good investment. Investing in ASND stocks now will result in a potential loss of 119.14%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -418.96 | -383.58 | -583.19 | -481.45 | -378.08 | -449.05 |
| YoY growth | -92.17% | 8.44% | -52.04% | 17.45% | 21.47% | -19.37% |
| Market Cap (mil) | 10,311.20 |
| P/E | |
| Forward P/E |
| EPS | -5.66 |
| Avg earnings growth rate | -19.37% |
| TTM earnings | -341.67 |